Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current

a technology of electrical current and nucleic acids, applied in the field of circuit arrangement, can solve the problems of low cell mortality, no circuit arrangement known so far, and no known circuit arrangemen

Inactive Publication Date: 2009-01-22
LONZA COLOGNE
View PDF28 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016]As a result of the circuit regulation of the pulse delivery, the transfer of the envisaged quantity of charge is thus monitored in a reliable and advantageous fashion at least for one pulse and a controlled and sample-dependent transfer of a preset quantity of charge as well as a controlled monitoring to avoid any damage to the cells located in the sample can be achieved.
[0017]For further safety of the user and the samples used it is provided that an overcurrent cutoff is provided for the first and each subsequent pulse. The overcurrent cutoff thus allows the high-voltage pulse to be interrupted at any time in the event that preset limiting values are exceeded.
[0024]The circuit arrangement described here generates very high field intensities of 2 to 10 kV / cm which have the effect that DNA and / or biologically active molecules can enter the nucleus independently of the cell division. These field intensities are far above those normally used for electroporation and far beyond those sufficient for efficient opening of the pores in the cell membrane (on average 1 kV / cm according to Lurquin, 1997, Mol. Biotechnol. 7, 5).
[0028]Since the circuit arrangement makes transfection possible regardless of the cell division, in addition to dividing cells, quiescent or weakly dividing primary cells can also be transfected.
[0031]The circuit arrangement according to the invention makes it possible to achieve transfection independent of cell division and thus to considerably speed up transfection experiments. In transfection experiments using expression vectors, an analysis according to promoter and expressed protein can be made even a few hours after the transfection.

Problems solved by technology

None of the circuit arrangements for electroporation known so far is concerned with bringing DNA electrically specifically into the nucleus of higher eukaryotic cells.
None of the circuit arrangements known so far is optimised to make it possible for DNA and / or other biologically active molecules to be effectively transported into the cell nucleus with low cell mortality.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current
  • Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current
  • Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current

Examples

Experimental program
Comparison scheme
Effect test

example 1

Transfection of Cytotoxic T Cells from Human Blood

[0039]Freshly prepared unstimulated (non-dividing) mononuclear cells from peripheral human blood (PBMC) were transfected with a vector which codes for the heavy chain of the mouse MHC class 1 protein H-2Kk. 5×106 cells together with 5 μg of vector DNA in a buffer having a high buffer capacity (48 mM×pH−1) and high ionic strength (280 mM) were placed at room temperature in a cuvette having a 2 mm interelectrode gap and transfected by a 1000 V pulse of 100 μs duration, followed by a current flow having a current density of 5 A·cm−2 and 40 ms. Immediately afterwards, the cells were washed from the cuvette using 400 μl of culture medium, incubated for 10 minutes at 37° C. and then transferred to a culture dish with pre-heated medium. After incubating for 24 h, the cells were successively incubated with digoxigenin-coupled anti-H-2Kk-antibody and Cy5-coupled anti-digoxigenin-antibody, as well as with a PerCP-coupled anti-CD8-antibody to i...

example 2

Transfection of Human Haematopoeitic Stem Cells (CD34)

[0040]CD34-positive cells were pre-enriched from freshly prepared PBMC described as in Example 1 by magnetic cell sorting. Respectively 1×104 CD34-positive cells were then mixed with 1×106 PBMCs, placed together with 5 μg H-2Kk-expression vector DNA in a buffer having a high buffer capacity (54 mM×pH−1) and high ionic strength (260 mM) at room temperature in a cuvette having a 2 mm interelectrode gap and transfected by a 1000 V pulse of 100 μs duration, followed by a current flow having a current density of 4 A·cm−2 and 20 ms duration. Immediately afterwards, the cells were washed from the cuvette using 400 μl of culture medium, incubated for 10 minutes at 37° C. and then transferred to a culture dish with pre-heated medium. After incubating for 16 h, the cells were successively incubated with phycoerythrin-coupled anti-H-2Kk-antibody, as well as with an APC-coupled anti-CD34 antibody to identify human haematopoietic stem cells a...

example 3

Transfection of Human Neonatal Dermal Fibroblasts (NHDF-Neo)

[0041]Human neonatal dermal fibroblasts (5×105 cells) together with 5 μg H-2Kk-expression vector DNA were placed in a buffer having a high buffer capacity (67 mM×pH−1) and high ionic strength (380 mM) at room temperature in a cuvette having a 2 mm interelectrode gap and transfected by a 1000 V pulse of 100 μs duration, followed by a current flow having a current density of 6 A·cm−2 and of 33 ms duration. Immediately afterwards, the cells were washed from the cuvette using 400 μl of culture medium, incubated for 10 minutes at 37° C. and then transferred to a culture dish with pre-heated medium. After incubating for 5 h, the cells were incubated with a Cy5-coupled anti-H-2Kk-antibody and analysed using a flow cytometer (FACScalibur, Becton Dickinson). The number of dead cells was determined by staining with propidium iodide. As shown in FIG. 3, 93% of the cells express the H-2Kk antigen which corresponds to a very high transf...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
current densityaaaaaaaaaa
current densityaaaaaaaaaa
current densityaaaaaaaaaa
Login to view more

Abstract

The invention relates to a novel circuit arrangement for electrotransfection or electrofusion, which enables the transportation of DNA and / or other biologically active molecules to the nucleus of higher eukaryotic cells or the fusion of cells, independent of cell division and with reduced cell mortality.

Description

CROSS-REFERENCE TO PRIOR APPLICATION[0001]This is a division of U.S. patent application Ser. No. 10 / 475,840, filed Oct. 21, 2003, which is the national stage of PCT / DE02 / 01489.BACKGROUND OF THE INVENTION[0002]The invention relates to a circuit arrangement for introducing nucleic acids, peptides, proteins and / or other biologically active molecules into the cell nucleus of eukaryotic cells by means of electric current, or for the treatment of cells, cell derivatives, subcellular particles and / or vesicles with electric current, consisting of at least two storage devices for quantities of electric charge, each supplied by a high-voltage power supply which each have at least one power semiconductor for transferring the quantities of charge present in the storage devices into a suspension in a cuvette and at least one monitoring device for controlling the power semiconductor.[0003]Since the place of action of eukaryotic DNA is the cell nucleus, DNA supplied from outside must enter the nuc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q3/00C12N15/09A61N1/32C12M1/00C12M1/42C12N15/82C12N15/87C12R1/91H02M9/04H03K3/015H03K3/57
CPCA61N1/0412H03K3/57C12N15/87A61N1/327C12N13/00
Inventor MULLER-HARTMANN, HERBERTRIEMEN, GUDULAROTHMANN-COSIC, KIRSTENTHIEL, CORINNAALTROGGE, LUDGERWEIGEL, MEIKECHRISTINE, RAINERLORBACH, ELKEHELFRICH, JULIANAWESSENDORF, HEIKESIEBENKOTTEN, GREGOR
Owner LONZA COLOGNE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap